RAY B — RaySearch Laboratories AB (publ) Balance Sheet
0.000.00%
- SEK6.29bn
- SEK6.27bn
- SEK1.34bn
Annual balance sheet for RaySearch Laboratories AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Interim Report | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 103 | 160 | 344 | 463 | 407 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 384 | 398 | 414 | 468 | 541 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 516 | 628 | 802 | 985 | 971 |
| Net Property, Plant And Equipment | 667 | 649 | 590 | 527 | 447 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,745 | 1,876 | 1,953 | 2,091 | 1,992 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 517 | 614 | 675 | 704 | 570 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,116 | 1,219 | 1,217 | 1,214 | 1,007 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 628 | 657 | 735 | 877 | 985 |
| Total Liabilities & Shareholders' Equity | 1,745 | 1,876 | 1,953 | 2,091 | 1,992 |
| Total Common Shares Outstanding |